Starton Therapeutics, Stanford School of Medicine Enter Clinical Trial Agreement for STAR-LLD, CAR-T Combination in Multiple Myeloma
Starton Therapeutics has signed a clinical trial agreement with the Stanford School of Medicine to evaluate STAR-LLD in combination with a novel CAR-T therapy for multiple myeloma, according to the company. Overview According to the company, the agreement establishes a clinical trial collaboration between Starton Therapeutics and the